Aoife Brennan – Biography
Last update: April 1, 2026Executive profile
Aoife was Vice President, Rare Disease Innovation Unit at Biogen, and Medical Director at Tolerx. Aoife Brennan joined Cerevance in 2024.
Aoife Brennan is currentlyPresident, Chief Executive Officer and Director at Climb Bio - View - Climb Bio org chart
Director at Cerevance - View - Cerevance org chart
Director at Xilio Therapeutics - View - Xilio Therapeutics org chart
Create your alert
to follow the career of Aoife Brennan.
Education
Aoife Brennan has a MRCPI Genreal Internal Medicine and Endocrinology from The Royal College of Physicians in Ireland and a Master of Medical Sciences & Translational Research from Harvard Medical School.
They have also studied at Harvard Medical School :
Find more alumni from Harvard Medical School
More about Aoife Brennan
Selected links
Do you need to know more about Aoife Brennan? More results.
Participate
Social media
- Aoife Brennan on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Aoife Brennan
The colleagues of Aoife Brennan
Company Colleagues
- At Climb Bio, Aoife Brennan has 21 colleagues including Judith Dunn (Director), Andrew Levin (Director)…
- At Cerevance, Aoife Brennan has 20 colleagues including Craig Thompson (CEO & Director), David Lubner (Director)…
- At Xilio Therapeutics, Aoife Brennan has 28 colleagues including Rene Russo (CEO & Director), Sara Bonstein (Chairman of the Board)…
Industry Colleagues
- In the Biotechnology industry, Aoife Brennan has 35,750 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Aoife Brennan.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Aoife Brennan.
